Total Payments
$5,768
2024 Payments
$1,200
Companies
40
Transactions
357
Medicare Patients
3,372
Medicare Billing
$331,055
Payment Breakdown by Category
Food & Beverage$5,614 (97.3%)
Education$153.49 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,614 | 354 | 97.3% |
| Education | $153.49 | 3 | 2.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $879.38 | 55 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $733.61 | 43 | $0 (2024) |
| ABBVIE INC. | $639.36 | 44 | $0 (2024) |
| GlaxoSmithKline, LLC. | $390.79 | 23 | $0 (2024) |
| Allergan, Inc. | $347.92 | 29 | $0 (2022) |
| PFIZER INC. | $316.99 | 21 | $0 (2024) |
| Astellas Pharma US Inc | $291.57 | 9 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $277.84 | 19 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $261.41 | 18 | $0 (2023) |
| Amgen Inc. | $192.05 | 14 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,200 | 57 | Novo Nordisk Inc ($181.87) |
| 2023 | $838.47 | 47 | Novo Nordisk Inc ($207.37) |
| 2022 | $776.48 | 52 | Novo Nordisk Inc ($183.82) |
| 2021 | $800.09 | 56 | AbbVie Inc. ($164.54) |
| 2020 | $703.17 | 48 | AstraZeneca Pharmaceuticals LP ($176.79) |
| 2019 | $644.37 | 40 | AstraZeneca Pharmaceuticals LP ($126.26) |
| 2018 | $632.81 | 45 | Allergan Inc. ($122.08) |
| 2017 | $171.98 | 12 | Novo Nordisk Inc ($47.29) |
All Payment Transactions
357 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Diabetes | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $122.09 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/15/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $9.24 | General |
| Category: Obesity | ||||||
| 11/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Cardio-renal | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Biological | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Respiratory | ||||||
| 09/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardio-renal | ||||||
| 09/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.41 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: VACCINES | ||||||
| 08/16/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 609 | 1,040 | $219,520 | $63,046 |
| 2022 | 14 | 818 | 1,340 | $185,160 | $84,717 |
| 2021 | 18 | 896 | 1,320 | $184,580 | $82,207 |
| 2020 | 20 | 1,049 | 1,560 | $242,725 | $101,086 |
Total Patients
3,372
Total Services
5,260
Medicare Billing
$331,055
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 195 | 475 | $142,565 | $37,362 | 26.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 102 | 102 | $30,520 | $12,096 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 107 | 167 | $35,425 | $9,144 | 25.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 63 | 63 | $1,950 | $1,792 | 91.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 63 | 63 | $3,135 | $1,377 | 43.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 95 | $3,800 | $737.00 | 19.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 14 | 14 | $1,820 | $403.77 | 22.2% |
| 81003 | Automated urinalysis test | Office | 2023 | 48 | 61 | $305.00 | $134.20 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 212 | 560 | $109,200 | $47,746 | 43.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 126 | 126 | $26,460 | $15,460 | 58.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 140 | 206 | $27,810 | $11,614 | 41.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 13 | 13 | $6,370 | $3,617 | 56.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 63 | 65 | $3,250 | $1,766 | 54.3% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 57 | 58 | $2,610 | $1,222 | 46.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 16 | 94 | $3,760 | $796.96 | 21.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 23 | 23 | $920.00 | $627.74 | 68.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 13 | 13 | $650.00 | $531.31 | 81.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 16 | $1,280 | $511.60 | 40.0% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 14 | 14 | $840.00 | $276.75 | 32.9% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2022 | 35 | 37 | $740.00 | $222.00 | 30.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 70 | 91 | $910.00 | $202.14 | 22.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 23 | 24 | $360.00 | $123.02 | 34.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 224 | 518 | $101,010 | $42,755 | 42.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 134 | 134 | $28,140 | $16,860 | 59.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 142 | 207 | $27,945 | $12,089 | 43.3% |
About Dr. Clay Stalcup, MD
Dr. Clay Stalcup, MD is a Family Medicine healthcare provider based in Seymour, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1750389979.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Clay Stalcup, MD has received a total of $5,768 in payments from pharmaceutical and medical device companies, with $1,200 received in 2024. These payments were reported across 357 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($5,614).
As a Medicare-enrolled provider, Stalcup has provided services to 3,372 Medicare beneficiaries, totaling 5,260 services with total Medicare billing of $331,055. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Seymour, TN
- Active Since 07/12/2005
- Last Updated 10/27/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1750389979
Products in Payments
- VRAYLAR (Drug) $617.97
- Ozempic (Drug) $350.11
- TRELEGY ELLIPTA (Drug) $321.90
- Rybelsus (Drug) $266.76
- FARXIGA (Drug) $261.54
- XARELTO (Drug) $199.11
- UBRELVY (Drug) $197.83
- SYMBICORT (Drug) $193.87
- JARDIANCE (Drug) $147.04
- Kerendia (Drug) $142.15
- Auvelity (Drug) $142.01
- Veozah (Drug) $133.30
- AIRSUPRA (Drug) $122.66
- Wegovy (Drug) $116.90
- Aimovig (Biological) $104.88
- CHANTIX (Drug) $99.05
- GVOKE PFS (Drug) $93.49
- BREZTRI AEROSPHERE (Drug) $92.29
- Vascepa (Drug) $89.18
- MOUNJARO (Drug) $84.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Seymour
Dr. Wesley Payne, M.d, M.D
Family Medicine — Payments: $15,301
Family Medicine $15,301
Garrett Rowe, Md, MD
Family Medicine — Payments: $8,632
Family Medicine $8,632
Dr. Bradley Morin, M.d, M.D
Family Medicine — Payments: $8,001
Family Medicine $8,001
Dr. Nicholas Lemming, Md, MD
Family Medicine — Payments: $7,667
Family Medicine $7,667
Dr. David Hartung, Do, DO
Family Medicine — Payments: $7,097
Family Medicine $7,097
Wayne Stuart, Do, DO
Family Medicine — Payments: $7,051
Family Medicine $7,051